Article
The Future of Targeted Therapy for Leiomyosarcoma
26 Feb 2024
Abstract excerpt
Leiomyosarcoma (LMS) is an aggressive subtype of soft tissue sarcoma that arises from smooth muscle cells, most commonly in the uterus and retroperitoneum. LMS is a heterogeneous disease with diverse clinical and molecular characteristics that have yet to be fully understood. Molecular profiling has uncovered possible targets amenable to treatment, though this has yet to translate into approved targeted therapies...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
